Artery Histology: Layers of Blood Vessel Walls

The wall of a blood vessel is composed of three layers: the tunica intima, tunica media, and tunica adventitia. The innermost layer, the tunica intima, is made up of endothelial cells that are separated by gap junctions. The middle layer, the tunica media, contains smooth muscle cells and is separated from the intima by the internal elastic lamina and from the adventitia by the external elastic lamina. The outermost layer, the tunica adventitia, contains the vasa vasorum, fibroblast, and collagen. This layer is responsible for providing support and protection to the blood vessel. The vasa vasorum are small blood vessels that supply oxygen and nutrients to the larger blood vessels. The fibroblast and collagen provide structural support to the vessel wall. Understanding the histology of arteries is important in diagnosing and treating various cardiovascular diseases.

The heart has four chambers and generates pressures of 0-25 mmHg on the right side and 0-120 mmHg on the left. The cardiac output is the product of heart rate and stroke volume, typically 5-6L per minute. The cardiac impulse is generated in the sino atrial node and conveyed to the ventricles via the atrioventricular node. Parasympathetic and sympathetic fibers project to the heart via the vagus and release acetylcholine and noradrenaline, respectively. The cardiac cycle includes mid diastole, late diastole, early systole, late systole, and early diastole. Preload is the end diastolic volume and afterload is the aortic pressure. Laplace’s law explains the rise in ventricular pressure during the ejection phase and why a dilated diseased heart will have impaired systolic function. Starling’s law states that an increase in end-diastolic volume will produce a larger stroke volume up to a point beyond which stroke volume will fall. Baroreceptor reflexes and atrial stretch receptors are involved in regulating cardiac output.

Diagnosis and Assessment of Biventricular Failure

This patient is exhibiting symptoms of both peripheral and pulmonary edema, indicating biventricular failure. The ECG shows left ventricular hypertrophy, which is likely due to her long-standing hypertension. While she is at an increased risk for a myocardial infarction as a diabetic and smoker, her low troponin T levels suggest that this is not the immediate cause of her symptoms. However, it is important to rule out acute coronary syndromes in diabetics, as they may not experience pain.

Mitral stenosis, if present, would be accompanied by a diastolic murmur and left atrial hypertrophy. In severe cases, back-pressure can lead to pulmonary edema. Overall, a thorough assessment and diagnosis of biventricular failure is crucial in determining the appropriate treatment plan for this patient.

Bivalirudin inhibits thrombin directly in a reversible manner.

Warfarin prevents the conversion of vitamin K to its active hydroquinone form by acting as an antagonist.

Heparins activate antithrombin II and also form inactive complexes with other clotting factors.

Aspirin inhibits COX.

Clopidogrel functions as a/an.

Bivalirudin: An Anticoagulant for Acute Coronary Syndrome

Bivalirudin is a medication that acts as a direct thrombin inhibitor, meaning it prevents the formation of blood clots. It is commonly used as an anticoagulant in the treatment of acute coronary syndrome, a condition where blood flow to the heart is blocked or reduced. Bivalirudin is a reversible inhibitor, meaning its effects can be reversed if necessary.

Acute coronary syndrome is a serious condition that can lead to heart attack or other complications if left untreated. Bivalirudin is an effective treatment option for preventing blood clots and reducing the risk of further complications. Its reversible nature also makes it a safer option for patients who may need to undergo surgery or other procedures while on anticoagulant therapy. Overall, bivalirudin is an important medication in the management of acute coronary syndrome and plays a crucial role in improving patient outcomes.

VCAM-1 is a protein expressed on endothelial cells in response to pro-atherosclerotic conditions. It binds to lymphocytes, monocytes, and eosinophils, causing adhesion to the endothelium. Its expression is upregulated by cytokines and is critical in the development of atherosclerosis.

Understanding Acute Coronary Syndrome

Acute coronary syndrome (ACS) is a term used to describe various acute presentations of ischaemic heart disease. It includes ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. ACS usually develops in patients with ischaemic heart disease, which is the gradual build-up of fatty plaques in the walls of the coronary arteries. This can lead to a gradual narrowing of the arteries, resulting in less blood and oxygen reaching the myocardium, causing angina. It can also lead to sudden plaque rupture, resulting in a complete occlusion of the artery and no blood or oxygen reaching the area of myocardium, causing a myocardial infarction.

There are many factors that can increase the chance of a patient developing ischaemic heart disease, including unmodifiable risk factors such as increasing age, male gender, and family history, and modifiable risk factors such as smoking, diabetes mellitus, hypertension, hypercholesterolaemia, and obesity.

The classic and most common symptom of ACS is chest pain, which is typically central or left-sided and may radiate to the jaw or left arm. Other symptoms include dyspnoea, sweating, and nausea and vomiting. Patients presenting with ACS often have very few physical signs, and the two most important investigations when assessing a patient with chest pain are an electrocardiogram (ECG) and cardiac markers such as troponin.

Once a diagnosis of ACS has been made, treatment involves preventing worsening of the presentation, revascularising the vessel if occluded, and treating pain. For patients who’ve had a STEMI, the priority of management is to reopen the blocked vessel. For patients who’ve had an NSTEMI, a risk stratification tool is used to decide upon further management. Patients who’ve had an ACS require lifelong drug therapy to help reduce the risk of a further event, which includes aspirin, a second antiplatelet if appropriate, a beta-blocker, an ACE inhibitor, and a statin.

Likely Diagnosis for Sudden Onset of Symptoms

When considering the sudden onset of symptoms, drug abuse is an unlikely cause as the symptoms are short-lived and not accompanied by other common drug abuse symptoms. Paroxysmal SVT would present with sudden starts and stops, rather than a gradual onset. Personality disorder and thyrotoxicosis would both lead to longer-lasting symptoms and other associated symptoms. Therefore, the most likely diagnosis for sudden onset symptoms would be panic disorder. It is important to consider all possible causes and seek medical attention to properly diagnose and treat any underlying conditions.

Infective endocarditis is the likely diagnosis, which can be suspected if there is a fever and a murmur. The presence of vegetations on echo and positive blood cultures that meet Duke criteria can confirm the diagnosis. Of the given options, the only known risk factor for infective endocarditis is getting a new piercing. Alcohol binging can increase the risk of alcoholic liver disease and dilated cardiomyopathy, while asbestos exposure can lead to asbestosis and mesothelioma. Marijuana smoking may be associated with psychosis and paranoia.

Aetiology of Infective Endocarditis

Infective endocarditis is a condition that affects patients with previously normal valves, rheumatic valve disease, prosthetic valves, congenital heart defects, intravenous drug users, and those who have recently undergone piercings. The strongest risk factor for developing infective endocarditis is a previous episode of the condition. The mitral valve is the most commonly affected valve.

The most common cause of infective endocarditis is Staphylococcus aureus, particularly in acute presentations and intravenous drug users. Historically, Streptococcus viridans was the most common cause, but this is no longer the case except in developing countries. Coagulase-negative Staphylococci such as Staphylococcus epidermidis are commonly found in indwelling lines and are the most common cause of endocarditis in patients following prosthetic valve surgery. Streptococcus bovis is associated with colorectal cancer, with the subtype Streptococcus gallolyticus being most linked to the condition.

Culture negative causes of infective endocarditis include prior antibiotic therapy, Coxiella burnetii, Bartonella, Brucella, and HACEK organisms (Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, Kingella). It is important to note that systemic lupus erythematosus and malignancy, specifically marantic endocarditis, can also cause non-infective endocarditis.

The Phases of Cardiac Action Potential

The cardiac action potential is a complex process that involves four distinct phases. The first phase, known as phase 0 or the depolarisation phase, is initiated by the opening of fast Na channels, which allows an influx of Na ions into the cell. This influx of positively charged ions creates a positive current that rapidly depolarises the cell membrane.

In the second phase, known as phase 1 or initial repolarisation, the fast Na channels close, causing a brief period of repolarisation. This is followed by phase 2 or the plateau phase, which is characterised by the opening of K and Ca channels. The influx of calcium ions into the cell is balanced by the efflux of potassium ions, resulting in a net neutral current.

The final phase, phase 3 or repolarisation, is initiated by the closure of Ca channels, which causes a net negative current as K+ ions continue to leave the cell. It is important to note that the inward movement of sodium alone would not result in a plateau, as it represents a positive current. The normal action of the sodium-potassium pump involves the inward movement of potassium combined with the outward movement of sodium.

Patients with reduced ejection fraction heart failure (HF-rEF) usually experience systolic dysfunction, which refers to the impaired ability of the myocardium to contract during systole.

Types of Heart Failure

Heart failure is a clinical syndrome where the heart cannot pump enough blood to meet the body’s metabolic needs. It can be classified in multiple ways, including by ejection fraction, time, and left/right side. Patients with heart failure may have a normal or abnormal left ventricular ejection fraction (LVEF), which is measured using echocardiography. Reduced LVEF is typically defined as < 35 to 40% and is termed heart failure with reduced ejection fraction (HF-rEF), while preserved LVEF is termed heart failure with preserved ejection fraction (HF-pEF). Heart failure can also be described as acute or chronic, with acute heart failure referring to an acute exacerbation of chronic heart failure. Left-sided heart failure is more common and may be due to increased left ventricular afterload or preload, while right-sided heart failure is caused by increased right ventricular afterload or preload. High-output heart failure is another type of heart failure that occurs when a normal heart is unable to pump enough blood to meet the body's metabolic needs. By classifying heart failure in these ways, healthcare professionals can better understand the underlying causes and tailor treatment plans accordingly. It is important to note that many guidelines for the management of heart failure only cover HF-rEF patients and do not address the management of HF-pEF patients. Understanding the different types of heart failure can help healthcare professionals provide more effective care for their patients.

These aneurysms are genuine and consist of all three layers of the arterial wall.

Understanding Abdominal Aortic Aneurysms

Abdominal aortic aneurysms occur when the elastic proteins in the extracellular matrix fail, causing the arterial wall to dilate. This is typically caused by degenerative disease and can be identified by a diameter of 3 cm or greater. The development of aneurysms is complex and involves the loss of the intima and elastic fibers from the media, which is associated with increased proteolytic activity and lymphocytic infiltration.

Smoking and hypertension are major risk factors for the development of aneurysms, while rare causes include syphilis and connective tissue diseases such as Ehlers Danlos type 1 and Marfan’s syndrome. It is important to understand the underlying causes and risk factors for abdominal aortic aneurysms in order to prevent and treat this potentially life-threatening condition.

The ophthalmic artery originates from the internal carotid artery, while the vertebral artery gives rise to the posterior inferior cerebellar artery. The internal carotid artery also has other branches, which can be found in the attached notes. Similarly, the basilar artery has its own set of branches.

The Circle of Willis is an anastomosis formed by the internal carotid arteries and vertebral arteries on the bottom surface of the brain. It is divided into two halves and is made up of various arteries, including the anterior communicating artery, anterior cerebral artery, internal carotid artery, posterior communicating artery, and posterior cerebral arteries. The circle and its branches supply blood to important areas of the brain, such as the corpus striatum, internal capsule, diencephalon, and midbrain.

The vertebral arteries enter the cranial cavity through the foramen magnum and lie in the subarachnoid space. They then ascend on the anterior surface of the medulla oblongata and unite to form the basilar artery at the base of the pons. The basilar artery has several branches, including the anterior inferior cerebellar artery, labyrinthine artery, pontine arteries, superior cerebellar artery, and posterior cerebral artery.

The internal carotid arteries also have several branches, such as the posterior communicating artery, anterior cerebral artery, middle cerebral artery, and anterior choroid artery. These arteries supply blood to different parts of the brain, including the frontal, temporal, and parietal lobes. Overall, the Circle of Willis and its branches play a crucial role in providing oxygen and nutrients to the brain.

An anterior MI is the most probable diagnosis, given the absence of ST changes in the inferior leads. Aortic dissection is therefore less probable.

The following table displays the relationship between ECG changes and the affected coronary artery territories. Anteroseptal changes in V1-V4 indicate involvement of the left anterior descending artery, while inferior changes in II, III, and aVF suggest the right coronary artery is affected. Anterolateral changes in V4-6, I, and aVL may indicate involvement of either the left anterior descending or left circumflex artery, while lateral changes in I, aVL, and possibly V5-6 suggest the left circumflex artery is affected. Posterior changes in V1-3 may indicate a posterior infarction, which is typically caused by the left circumflex artery but can also be caused by the right coronary artery. Reciprocal changes of STEMI are often seen as horizontal ST depression, tall R waves, upright T waves, and a dominant R wave in V2. Posterior infarction is confirmed by ST elevation and Q waves in posterior leads (V7-9), usually caused by the left circumflex artery but also possibly the right coronary artery. It is important to note that a new LBBB may indicate acute coronary syndrome.

Diagram showing the correlation between ECG changes and coronary territories in acute coronary syndrome.

Rheumatic heart fever is characterized by the presence of Aschoff bodies, which are granulomatous nodules. The mitral valve is commonly affected in this condition, and an elevated ASO titre indicates exposure to group A streptococcus bacteria. Rheumatic heart disease is also associated with the presence of Anitschkow cells, which are enlarged macrophages with an ovoid, wavy, rod-like nucleus. Other types of bodies seen in different conditions include Councilman bodies in hepatitis C and yellow fever, Mallory bodies in alcoholism affecting hepatocytes, and Call-Exner bodies in granulosa cell tumours.

Rheumatic fever is a condition that occurs as a result of an immune response to a recent Streptococcus pyogenes infection, typically occurring 2-4 weeks after the initial infection. The pathogenesis of rheumatic fever involves the activation of the innate immune system, leading to antigen presentation to T cells. B and T cells then produce IgG and IgM antibodies, and CD4+ T cells are activated. This immune response is thought to be cross-reactive, mediated by molecular mimicry, where antibodies against M protein cross-react with myosin and the smooth muscle of arteries. This response leads to the clinical features of rheumatic fever, including Aschoff bodies, which are granulomatous nodules found in rheumatic heart fever.

To diagnose rheumatic fever, evidence of recent streptococcal infection must be present, along with 2 major criteria or 1 major criterion and 2 minor criteria. Major criteria include erythema marginatum, Sydenham’s chorea, polyarthritis, carditis and valvulitis, and subcutaneous nodules. Minor criteria include raised ESR or CRP, pyrexia, arthralgia, and prolonged PR interval.

Management of rheumatic fever involves antibiotics, typically oral penicillin V, as well as anti-inflammatories such as NSAIDs as first-line treatment. Any complications that develop, such as heart failure, should also be treated. It is important to diagnose and treat rheumatic fever promptly to prevent long-term complications such as rheumatic heart disease.

The Circle of Willis is an anastomosis formed by the internal carotid arteries and vertebral arteries on the bottom surface of the brain. It is divided into two halves and is made up of various arteries, including the anterior communicating artery, anterior cerebral artery, internal carotid artery, posterior communicating artery, and posterior cerebral arteries. The circle and its branches supply blood to important areas of the brain, such as the corpus striatum, internal capsule, diencephalon, and midbrain.

The vertebral arteries enter the cranial cavity through the foramen magnum and lie in the subarachnoid space. They then ascend on the anterior surface of the medulla oblongata and unite to form the basilar artery at the base of the pons. The basilar artery has several branches, including the anterior inferior cerebellar artery, labyrinthine artery, pontine arteries, superior cerebellar artery, and posterior cerebral artery.

The internal carotid arteries also have several branches, such as the posterior communicating artery, anterior cerebral artery, middle cerebral artery, and anterior choroid artery. These arteries supply blood to different parts of the brain, including the frontal, temporal, and parietal lobes. Overall, the Circle of Willis and its branches play a crucial role in providing oxygen and nutrients to the brain.

Hypokalaemia can be identified through a prolonged PR interval on an ECG. However, this same ECG sign may also be present in cases of hyperkalaemia. Additional ECG signs of hypokalaemia include small or absent P waves, tall tented T waves, and broad bizarre QRS complexes. On the other hand, hyperkalaemia can be identified through ECG signs such as long PR intervals, a sine wave pattern, and tall tented T waves, as well as broad bizarre QRS complexes.

Hypokalaemia, a condition characterized by low levels of potassium in the blood, can be detected through ECG features. These include the presence of U waves, small or absent T waves (which may occasionally be inverted), a prolonged PR interval, ST depression, and a long QT interval. The ECG image provided shows typical U waves and a borderline PR interval. To remember these features, one user suggests the following rhyme: In Hypokalaemia, U have no Pot and no T, but a long PR and a long QT.

Atrial fibrillation occurs when irregular electrical activity from the myocytes surrounding the pulmonary veins overwhelms the regular impulses from the sinus node. This leads to discordance of electrical activity in the atria, causing the irregularly irregular tachycardia characteristic of AF. It is important to note that AF is not caused by an absence of electrical activity in the atria or bundle of His.

Atrial fibrillation (AF) is a heart condition that requires prompt management. The management of AF depends on the patient’s haemodynamic stability and the duration of the AF. For haemodynamically unstable patients, electrical cardioversion is recommended. For haemodynamically stable patients, rate control is the first-line treatment strategy, except in certain cases. Medications such as beta-blockers, calcium channel blockers, and digoxin are commonly used to control the heart rate. Rhythm control is another treatment option that involves the use of medications such as beta-blockers, dronedarone, and amiodarone. Catheter ablation is recommended for patients who have not responded to or wish to avoid antiarrhythmic medication. The procedure involves the use of radiofrequency or cryotherapy to ablate the faulty electrical pathways that cause AF. Anticoagulation is necessary before and during the procedure to reduce the risk of stroke. The success rate of catheter ablation varies, with around 50% of patients experiencing an early recurrence of AF within three months. However, after three years, around 55% of patients who have undergone a single procedure remain in sinus rhythm.

A false lumen in the descending aorta is a significant indication of aortic dissection on CT angiography. This condition is characterized by tearing chest pain, hypertension, and aortic regurgitation, which can be detected through a diastolic murmur over the 2nd intercostal space, right sternal border. The false lumen is formed due to a tear in the tunica intima of the aortic wall, which fills with a large volume of blood and is easily visible on angiographic CT.

Ballooning of the aortic arch is an incorrect answer as it refers to an aneurysm, which is a condition where the artery walls weaken and abnormally bulge out or widen. Aneurysms are prone to rupture and can have varying effects depending on their location.

Blurring of the posterior wall of the descending aorta is also an incorrect answer as it is a sign of a retroperitoneal, contained rupture of an aortic aneurysm. This condition may present with hypovolemic shock, hypotension, tachycardia, and tachypnea, leading to collapse.

Total occlusion of the left anterior descending artery is another incorrect answer as it would likely result in ST-elevation myocardial infarction (STEMI). Although chest pain is a symptom of both conditions, the nature of the pain and investigation findings make aortic dissection more likely. It is important to note that coronary arteries can only be viewed through coronary angiography, which involves injecting contrast directly into the coronary arteries using a catheter, and not through CT angiography.

Aortic dissection is classified according to the location of the tear in the aorta. The Stanford classification divides it into type A, which affects the ascending aorta in two-thirds of cases, and type B, which affects the descending aorta distal to the left subclavian origin in one-third of cases. The DeBakey classification divides it into type I, which originates in the ascending aorta and propagates to at least the aortic arch and possibly beyond it distally, type II, which originates in and is confined to the ascending aorta, and type III, which originates in the descending aorta and rarely extends proximally but will extend distally.

To diagnose aortic dissection, a chest x-ray may show a widened mediastinum, but CT angiography of the chest, abdomen, and pelvis is the investigation of choice. However, the choice of investigations should take into account the patient’s clinical stability, as they may present acutely and be unstable. Transoesophageal echocardiography (TOE) is more suitable for unstable patients who are too risky to take to the CT scanner.

The management of type A aortic dissection is surgical, but blood pressure should be controlled to a target systolic of 100-120 mmHg while awaiting intervention. On the other hand, type B aortic dissection is managed conservatively with bed rest and IV labetalol to reduce blood pressure and prevent progression. Complications of a backward tear include aortic incompetence/regurgitation and MI, while complications of a forward tear include unequal arm pulses and BP, stroke, and renal failure. Endovascular repair of type B aortic dissection may have a role in the future.

The upper limb has both superficial and deep veins. Among the superficial veins are the cephalic, basilic, and median cubital veins. The median cubital vein, which connects the cephalic and basilic veins, is situated in the antecubital fossa and is the preferred site for venepuncture because it is easy to locate and access. However, deep veins like the brachial, ulnar, and radial veins are not suitable for venepuncture as they are located beneath the deep fascia.

The Cephalic Vein: Path and Connections

The cephalic vein is a major blood vessel that runs along the lateral side of the arm. It begins at the dorsal venous arch, which drains blood from the hand and wrist, and travels up the arm, crossing the anatomical snuffbox. At the antecubital fossa, the cephalic vein is connected to the basilic vein by the median cubital vein. This connection is commonly used for blood draws and IV insertions.

After passing through the antecubital fossa, the cephalic vein continues up the arm and pierces the deep fascia of the deltopectoral groove to join the axillary vein. This junction is located near the shoulder and marks the end of the cephalic vein’s path.

Overall, the cephalic vein plays an important role in the circulation of blood in the upper limb. Its connections to other major veins in the arm make it a valuable site for medical procedures, while its path through the deltopectoral groove allows it to contribute to the larger network of veins that drain blood from the upper body.

Preserving the cephalic vein is important for creating an arteriovenous fistula in patients with end stage renal failure, as it is a preferred vessel for this purpose. The vein travels through the calvipectoral fascia, but does not pass through the pectoralis major muscle, before ending in the axillary vein.

The Cephalic Vein: Path and Connections

The cephalic vein is a major blood vessel that runs along the lateral side of the arm. It begins at the dorsal venous arch, which drains blood from the hand and wrist, and travels up the arm, crossing the anatomical snuffbox. At the antecubital fossa, the cephalic vein is connected to the basilic vein by the median cubital vein. This connection is commonly used for blood draws and IV insertions.

After passing through the antecubital fossa, the cephalic vein continues up the arm and pierces the deep fascia of the deltopectoral groove to join the axillary vein. This junction is located near the shoulder and marks the end of the cephalic vein’s path.

Overall, the cephalic vein plays an important role in the circulation of blood in the upper limb. Its connections to other major veins in the arm make it a valuable site for medical procedures, while its path through the deltopectoral groove allows it to contribute to the larger network of veins that drain blood from the upper body.

The Purkinje fibres have the highest conduction velocities in the heart’s electrical conduction system. The process starts with the SA node generating spontaneous action potentials, which are then conducted across both atria through cell to cell conduction at a speed of approximately 1 m/s. The only pathway for the action potential to enter the ventricles is through the AV node, which has a slow conduction speed of 0.05ms to allow for complete atrial contraction and ventricular filling. The action potentials are then conducted through the Bundle of His, which splits into the left and right bundle branches, with a conduction speed of approximately 2m/s. Finally, the action potential reaches the Purkinje fibres, which are specialized conducting cells that allow for a faster conduction speed of 2-4m/s. This fast conduction speed is crucial for a synchronized and efficient contraction of the ventricle, generating pressure during systole.

Understanding the Cardiac Action Potential and Conduction Velocity

The cardiac action potential is a series of electrical events that occur in the heart during each heartbeat. It is responsible for the contraction of the heart muscle and the pumping of blood throughout the body. The action potential is divided into five phases, each with a specific mechanism. The first phase is rapid depolarization, which is caused by the influx of sodium ions. The second phase is early repolarization, which is caused by the efflux of potassium ions. The third phase is the plateau phase, which is caused by the slow influx of calcium ions. The fourth phase is final repolarization, which is caused by the efflux of potassium ions. The final phase is the restoration of ionic concentrations, which is achieved by the Na+/K+ ATPase pump.

Conduction velocity is the speed at which the electrical signal travels through the heart. The speed varies depending on the location of the signal. Atrial conduction spreads along ordinary atrial myocardial fibers at a speed of 1 m/sec. AV node conduction is much slower, at 0.05 m/sec. Ventricular conduction is the fastest in the heart, achieved by the large diameter of the Purkinje fibers, which can achieve velocities of 2-4 m/sec. This allows for a rapid and coordinated contraction of the ventricles, which is essential for the proper functioning of the heart. Understanding the cardiac action potential and conduction velocity is crucial for diagnosing and treating heart conditions.

The most likely diagnosis for a patient with global ST and PR segment changes is pericarditis. This condition is characterized by inflammation of the pericardium, which often occurs after a respiratory illness. Patients with pericarditis typically experience sharp chest pain that worsens with inspiration or lying down and improves when leaning forward.

While benign early repolarization (BER) can also cause ST elevation, it is less likely in this case as the patient’s symptoms are more consistent with pericarditis. Additionally, BER often presents with a fish hook pattern on the ECG.

Infective endocarditis, pulmonary embolism (PE), and myocardial infarction (MI) are less likely diagnoses. Infective endocarditis typically presents with fever and a murmur, while PE is associated with tachycardia, haemoptysis, and signs of deep vein thrombosis. MI is usually confined to a specific territory on the ECG and is unlikely in a patient with low cardiac risk factors.

Acute Pericarditis: Causes, Features, Investigations, and Management

Acute pericarditis is a possible diagnosis for patients presenting with chest pain. The condition is characterized by chest pain, which may be pleuritic and relieved by sitting forwards. Other symptoms include non-productive cough, dyspnoea, and flu-like symptoms. Tachypnoea and tachycardia may also be present, along with a pericardial rub.

The causes of acute pericarditis include viral infections, tuberculosis, uraemia, trauma, post-myocardial infarction, Dressler’s syndrome, connective tissue disease, hypothyroidism, and malignancy.

Investigations for acute pericarditis include ECG changes, which are often global/widespread, as opposed to the ‘territories’ seen in ischaemic events. The ECG may show ‘saddle-shaped’ ST elevation and PR depression, which is the most specific ECG marker for pericarditis. All patients with suspected acute pericarditis should have transthoracic echocardiography.

Management of acute pericarditis involves treating the underlying cause. A combination of NSAIDs and colchicine is now generally used as first-line treatment for patients with acute idiopathic or viral pericarditis.

In summary, acute pericarditis is a possible diagnosis for patients presenting with chest pain. The condition is characterized by chest pain, which may be pleuritic and relieved by sitting forwards, along with other symptoms. The causes of acute pericarditis are varied, and investigations include ECG changes and transthoracic echocardiography. Management involves treating the underlying cause and using a combination of NSAIDs and colchicine as first-line treatment.

BNP is produced by the ventricles of the heart when the cardiomyocytes are excessively stretched. Its overall effect is to reduce blood pressure by decreasing systemic vascular resistance and increasing natriuresis.

Troponin is a protein that plays a role in cardiac muscle contraction and is a specific and sensitive marker for myocardial damage in cases of myocardial infarction.

Creatine kinase and LDH can be used as acute markers for myocardial infarction.

Myoglobin is released after muscle damage, but it is not specific to acute myocardial infarction and is typically measured in cases of rhabdomyolysis.

B-type natriuretic peptide (BNP) is a hormone that is primarily produced by the left ventricular myocardium in response to strain. Although heart failure is the most common cause of elevated BNP levels, any condition that causes left ventricular dysfunction, such as myocardial ischemia or valvular disease, may also raise levels. In patients with chronic kidney disease, reduced excretion may also lead to elevated BNP levels. Conversely, treatment with ACE inhibitors, angiotensin-2 receptor blockers, and diuretics can lower BNP levels.

BNP has several effects, including vasodilation, diuresis, natriuresis, and suppression of both sympathetic tone and the renin-angiotensin-aldosterone system. Clinically, BNP is useful in diagnosing patients with acute dyspnea. A low concentration of BNP (<100 pg/mL) makes a diagnosis of heart failure unlikely, but elevated levels should prompt further investigation to confirm the diagnosis. Currently, NICE recommends BNP as a helpful test to rule out a diagnosis of heart failure. In patients with chronic heart failure, initial evidence suggests that BNP is an extremely useful marker of prognosis and can guide treatment. However, BNP is not currently recommended for population screening for cardiac dysfunction.

The final stage in the development of an atheroma involves the proliferation and migration of smooth muscle from the tunica media into the intima. While monocytes do migrate, they differentiate into macrophages which then phagocytose LDLs and form foam cells. Additionally, there is infiltration of LDLs. The formation of fibrous capsules is a result of the smooth muscle proliferation and migration. Atherosclerosis is also associated with a reduction in nitric oxide availability.

Understanding Atherosclerosis and its Complications

Atherosclerosis is a complex process that occurs over several years. It begins with endothelial dysfunction triggered by factors such as smoking, hypertension, and hyperglycemia. This leads to changes in the endothelium, including inflammation, oxidation, proliferation, and reduced nitric oxide bioavailability. As a result, low-density lipoprotein (LDL) particles infiltrate the subendothelial space, and monocytes migrate from the blood and differentiate into macrophages. These macrophages then phagocytose oxidized LDL, slowly turning into large ‘foam cells’. Smooth muscle proliferation and migration from the tunica media into the intima result in the formation of a fibrous capsule covering the fatty plaque.

Once a plaque has formed, it can cause several complications. For example, it can form a physical blockage in the lumen of the coronary artery, leading to reduced blood flow and oxygen to the myocardium, resulting in angina. Alternatively, the plaque may rupture, potentially causing a complete occlusion of the coronary artery and resulting in a myocardial infarction. It is essential to understand the process of atherosclerosis and its complications to prevent and manage cardiovascular diseases effectively.

Importance of Confirming Persistent High Blood Pressure

While reducing high blood pressure is crucial, it is important to confirm that it is persistent and not just a one-time occurrence. Anxiety or other factors could artificially elevate blood pressure readings. Therefore, it is necessary to conduct multiple tests to confirm the diagnosis. Additionally, lifestyle changes such as exercise, healthy eating, and stress reduction can help lower blood pressure and improve overall health. Prescribing medication should only be done when necessary, as it can lead to side effects, drug interactions, and poor adherence. It is important to consider the risks and benefits before prescribing medication and to prioritize non-pharmacological interventions whenever possible. For more information, refer to the NICE guidelines on hypertension.

Anteroseptal myocardial infarction is typically caused by blockage of the left anterior descending artery. This is supported by the patient’s symptoms and ST segment elevation in leads V1-V4, which correspond to the territory supplied by this artery. Other potential occlusions, such as the left circumflex artery, left marginal artery, posterior descending artery, or right coronary artery, would cause different changes in specific leads.

The following table displays the relationship between ECG changes and the affected coronary artery territories. Anteroseptal changes in V1-V4 indicate involvement of the left anterior descending artery, while inferior changes in II, III, and aVF suggest the right coronary artery is affected. Anterolateral changes in V4-6, I, and aVL may indicate involvement of either the left anterior descending or left circumflex artery, while lateral changes in I, aVL, and possibly V5-6 suggest the left circumflex artery is affected. Posterior changes in V1-3 may indicate a posterior infarction, which is typically caused by the left circumflex artery but can also be caused by the right coronary artery. Reciprocal changes of STEMI are often seen as horizontal ST depression, tall R waves, upright T waves, and a dominant R wave in V2. Posterior infarction is confirmed by ST elevation and Q waves in posterior leads (V7-9), usually caused by the left circumflex artery but also possibly the right coronary artery. It is important to note that a new LBBB may indicate acute coronary syndrome.

Diagram showing the correlation between ECG changes and coronary territories in acute coronary syndrome.

At its origin from the common carotid, the internal carotid artery is located at the posterolateral position in relation to the external carotid artery. Its anterior surface gives rise to the superior thyroid, lingual, and facial arteries.

Anatomy of the External Carotid Artery

The external carotid artery begins on the side of the pharynx and runs in front of the internal carotid artery, behind the posterior belly of digastric and stylohyoid muscles. It is covered by sternocleidomastoid muscle and passed by hypoglossal nerves, lingual and facial veins. The artery then enters the parotid gland and divides into its terminal branches within the gland.

To locate the external carotid artery, an imaginary line can be drawn from the bifurcation of the common carotid artery behind the angle of the jaw to a point in front of the tragus of the ear.

The external carotid artery has six branches, with three in front, two behind, and one deep. The three branches in front are the superior thyroid, lingual, and facial arteries. The two branches behind are the occipital and posterior auricular arteries. The deep branch is the ascending pharyngeal artery. The external carotid artery terminates by dividing into the superficial temporal and maxillary arteries within the parotid gland.

Thiazide-like drugs such as indapamide work by blocking the Na+-Cl− symporter at the beginning of the distal convoluted tubule, which inhibits sodium reabsorption. Loop diuretics, on the other hand, inhibit the Na+ K+ 2Cl- cotransporters in the thick ascending loop of Henle. Amiloride, a potassium-sparing diuretic, inhibits the epithelial sodium channels in the cortical collecting ducts, while spironolactone, another potassium-sparing diuretic, blocks the action of aldosterone on aldosterone receptors and inhibits the Na+/K+ exchanger in the cortical collecting ducts.

Thiazide diuretics are medications that work by blocking the thiazide-sensitive Na+-Cl− symporter, which inhibits sodium reabsorption at the beginning of the distal convoluted tubule (DCT). This results in the loss of potassium as more sodium reaches the collecting ducts. While thiazide diuretics are useful in treating mild heart failure, loop diuretics are more effective in reducing overload. Bendroflumethiazide was previously used to manage hypertension, but recent NICE guidelines recommend other thiazide-like diuretics such as indapamide and chlorthalidone.

Common side effects of thiazide diuretics include dehydration, postural hypotension, and electrolyte imbalances such as hyponatremia, hypokalemia, and hypercalcemia. Other potential adverse effects include gout, impaired glucose tolerance, and impotence. Rare side effects may include thrombocytopenia, agranulocytosis, photosensitivity rash, and pancreatitis.

It is worth noting that while thiazide diuretics may cause hypercalcemia, they can also reduce the incidence of renal stones by decreasing urinary calcium excretion. According to current NICE guidelines, the management of hypertension involves the use of thiazide-like diuretics, along with other medications and lifestyle changes, to achieve optimal blood pressure control and reduce the risk of cardiovascular disease.

The cause of pulmonary vasoconstriction in primary pulmonary hypertension is endothelin, which is why antagonists are used to treat the condition. This is supported by the symptoms and diagnostic findings in a woman between the ages of 20 and 50. Other options such as bradykinin, iloprost, and nitric oxide are not vasoconstrictors and do not play a role in the development of pulmonary hypertension.

Understanding Endothelin and Its Role in Various Diseases

Endothelin is a potent vasoconstrictor and bronchoconstrictor that is secreted by the vascular endothelium. Initially, it is produced as a prohormone and later converted to ET-1 by the action of endothelin converting enzyme. Endothelin interacts with a G-protein linked to phospholipase C, leading to calcium release. This interaction is thought to be important in the pathogenesis of many diseases, including primary pulmonary hypertension, cardiac failure, hepatorenal syndrome, and Raynaud’s.

Endothelin is known to promote the release of angiotensin II, ADH, hypoxia, and mechanical shearing forces. On the other hand, it inhibits the release of nitric oxide and prostacyclin. Raised levels of endothelin are observed in primary pulmonary hypertension, myocardial infarction, heart failure, acute kidney injury, and asthma.

In recent years, endothelin antagonists have been used to treat primary pulmonary hypertension. Understanding the role of endothelin in various diseases can help in the development of new treatments and therapies.

Warfarin leads to an extended prothrombin time, which is the correct answer. The prothrombin time assesses the extrinsic and common pathways of the clotting cascade, and warfarin affects factor VII from the extrinsic pathway, as well as factor II (prothrombin) and factor X from the common pathway. This results in a prolonged prothrombin time, and the INR is a ratio of the prothrombin time during warfarin treatment to the normal prothrombin time.

The activated partial thromboplastin time is an incorrect answer. Although high levels of warfarin may prolong the activated partial thromboplastin time, the INR is solely based on the prothrombin time.

Bleeding time is also an incorrect answer. While warfarin can cause a prolonged bleeding time, the INR measures the prothrombin time.

Fibrinogen levels are another incorrect answer. Fibrinogen is necessary for blood clotting, and warfarin can decrease fibrinogen levels after prolonged use. However, fibrinogen levels are not used in the INR measurement.

Understanding Warfarin: Mechanism of Action, Indications, Monitoring, Factors, and Side-Effects

Warfarin is an oral anticoagulant that has been widely used for many years to manage venous thromboembolism and reduce stroke risk in patients with atrial fibrillation. However, it has been largely replaced by direct oral anticoagulants (DOACs) due to their ease of use and lack of need for monitoring. Warfarin works by inhibiting epoxide reductase, which prevents the reduction of vitamin K to its active hydroquinone form. This, in turn, affects the carboxylation of clotting factor II, VII, IX, and X, as well as protein C.

Warfarin is indicated for patients with mechanical heart valves, with the target INR depending on the valve type and location. Mitral valves generally require a higher INR than aortic valves. It is also used as a second-line treatment after DOACs for venous thromboembolism and atrial fibrillation, with target INRs of 2.5 and 3.5 for recurrent cases. Patients taking warfarin are monitored using the INR, which may take several days to achieve a stable level. Loading regimes and computer software are often used to adjust the dose.

Factors that may potentiate warfarin include liver disease, P450 enzyme inhibitors, cranberry juice, drugs that displace warfarin from plasma albumin, and NSAIDs that inhibit platelet function. Warfarin may cause side-effects such as haemorrhage, teratogenic effects, skin necrosis, temporary procoagulant state, thrombosis, and purple toes.

In summary, understanding the mechanism of action, indications, monitoring, factors, and side-effects of warfarin is crucial for its safe and effective use in patients. While it has been largely replaced by DOACs, warfarin remains an important treatment option for certain patients.

ACE inhibitors are prodrugs that require activation through phase 1 metabolism in the liver, except for captopril and lisinopril which are administered as active drugs. The hepatic esterolysis process converts ACE inhibitors into their active metabolite, allowing them to function as subtype 1B prodrugs. It is important to note that ACE inhibitors are not activated at the site of therapeutic action, and belong to subtype 1A and 2C prodrugs that are activated intracellularly or extracellularly at the therapeutic site, respectively. Answer 3 is a distractor, as ACE inhibitors do not activate ACE in the lung, but rather inhibit its activity. Answer 5 is also incorrect, as most ACE inhibitors require activation through metabolism.

Angiotensin-converting enzyme (ACE) inhibitors are commonly used as the first-line treatment for hypertension and heart failure in younger patients. However, they may not be as effective in treating hypertensive Afro-Caribbean patients. ACE inhibitors are also used to treat diabetic nephropathy and prevent ischaemic heart disease. These drugs work by inhibiting the conversion of angiotensin I to angiotensin II and are metabolized in the liver.

While ACE inhibitors are generally well-tolerated, they can cause side effects such as cough, angioedema, hyperkalaemia, and first-dose hypotension. Patients with certain conditions, such as renovascular disease, aortic stenosis, or hereditary or idiopathic angioedema, should use ACE inhibitors with caution or avoid them altogether. Pregnant and breastfeeding women should also avoid these drugs.

Patients taking high-dose diuretics may be at increased risk of hypotension when using ACE inhibitors. Therefore, it is important to monitor urea and electrolyte levels before and after starting treatment, as well as any changes in creatinine and potassium levels. Acceptable changes include a 30% increase in serum creatinine from baseline and an increase in potassium up to 5.5 mmol/l. Patients with undiagnosed bilateral renal artery stenosis may experience significant renal impairment when using ACE inhibitors.

The current NICE guidelines recommend using a flow chart to manage hypertension, with ACE inhibitors as the first-line treatment for patients under 55 years old. However, individual patient factors and comorbidities should be taken into account when deciding on the best treatment plan.